Literature DB >> 18284628

Age-matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis.

Sabine Huenecke1, Michael Behl, Carla Fadler, Stefanie Y Zimmermann, Konrad Bochennek, Lars Tramsen, Ruth Esser, Dieter Klarmann, Martina Kamper, Alexandra Sattler, Dorothee von Laer, Thomas Klingebiel, Thomas Lehrnbecher, Ulrike Koehl.   

Abstract

BACKGROUND: Normal values of lymphocyte subpopulations for healthy children and adults have been published in defined age groups exclusively, which results in difficult data interpretation for patients close to the limit of contiguous age group ranges. In addition, normal values for a number of lymphocyte subpopulations have not been established to date.
OBJECTIVE: The aim of this study was to develop a model which provides continuous age-dependent reference values. This model was applied for lymphocyte subpopulations such as naïve and memory T cells as well as their activation profile with diagnostic relevance in children and adults. STUDY
DESIGN: A total of 100 blood samples, obtained from 80 healthy children and 20 adults were analysed by means of four colour-flow cytometry. Continuous age-dependent reference values were computed based on the residual values in an exponential regression model.
RESULTS: We calculated a continuous age-related regression model for both, absolute cell counts and percentages of CD3(+)CD4(+) T helper (T(H)) cells, CD3(+)CD8(+) cytotoxic T cells, CD56(+)CD3(-) natural killer (NK) cells, CD56(+)CD3(+) T cells, CD3(+)CD4(+)CD45RA(+) naïve T(H) cells, CD3(+)CD4(+)CD45RO(+) memory T(H) cells, CD3(+)CD8(+)CD45RA(+)CD28(+) naïve cytotoxic T cells, CD3(+)CD8(+)CD45RO(+) memory cytotoxic T cells, CD3(+)CD8(+)CD69(+) early activated cytotoxic T cells and CD3(+)CD8(+)HLA-DR(+) late activated cytotoxic T cells, respectively, to obtain reference values.
CONCLUSION: Based on an exponential regression model, the obtained reference values reflect the continuous maturation of lymphocyte subsets during childhood.

Entities:  

Mesh:

Year:  2008        PMID: 18284628     DOI: 10.1111/j.1600-0609.2008.01052.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  39 in total

1.  Influence of sex, age, pubertal maturation and body mass index on circulating white blood cell counts in healthy European adolescents—the HELENA study.

Authors:  Fátima Pérez-de-Heredia; Sonia Gómez-Martínez; Ligia-Esperanza Díaz; Ana M Veses; Esther Nova; Julia Wärnberg; Inge Huybrechts; Krishna Vyncke; Odysseas Androutsos; Marika Ferrari; Gonzalo Palacios; Acki Wastlund; Éva Kovács; Frédéric Gottrand; Marcela González-Gross; Manuel J Castillo; Michael Sjöstrom; Yannis Manios; Anthony Kafatos; Denes Molnár; Kurt Widhalm; Luis A Moreno; Ascensión Marcos
Journal:  Eur J Pediatr       Date:  2015-02-10       Impact factor: 3.183

2.  Reference values of lymphocyte subsets in healthy, HIV-negative children in Cameroon.

Authors:  Bertrand Sagnia; Francis Ateba Ndongo; Suzie Ndiang Moyo Tetang; Judith Ndongo Torimiro; Cristiana Cairo; Irenée Domkam; Geraldine Agbor; Emmanuel Mve; Olive Tocke; Emilien Fouda; Odile Ouwe Missi Oukem-Boyer; Vittorio Colizzi
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

3.  Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.

Authors:  Kristjana H Ásbjörnsdóttir; James P Hughes; Dalton Wamalwa; Agnes Langat; Jennifer A Slyker; Hellen M Okinyi; Julie Overbaugh; Sarah Benki-Nugent; Kenneth Tapia; Elizabeth Maleche-Obimbo; Ali Rowhani-Rahbar; Grace John-Stewart
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

4.  Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.

Authors:  Renata Baffelli; Lucia D Notarangelo; Luisa Imberti; Michael S Hershfield; Federico Serana; Ines Santisteban; Federica Bolda; Fulvio Porta; Arnalda Lanfranchi
Journal:  J Clin Immunol       Date:  2015-09-16       Impact factor: 8.317

5.  Quantifying the development of the peripheral naive CD4+ T-cell pool in humans.

Authors:  Iren Bains; Rustom Antia; Robin Callard; Andrew J Yates
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

6.  MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia.

Authors:  Manuela Germeshausen; Phil Ancliff; Jaime Estrada; Markus Metzler; Eva Ponstingl; Horst Rütschle; Dirk Schwabe; Richard H Scott; Sule Unal; Angela Wawer; Bernward Zeller; Matthias Ballmaier
Journal:  Blood Adv       Date:  2018-03-27

7.  CD31 Expression on CD4+ Cells: A Simple Method for Quantitation of Recent Thymus Emigrant CD4 Cells.

Authors:  Ramia Zakhour; Dat Q Tran; Gloria P Heresi; Guenet Degaffe; Cynthia S Bell; Elizabeth Donnachie; Weihe Zhang; Norma Pérez; Laura J Benjamins; Gabriela Del Bianco; Gilhen Rodriguez; James R Murphy
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

8.  Local bone-marrow exposure: how to interpret the data on stable chromosome aberrations in circulating lymphocytes? (some comments on the use of FISH method for dose reconstruction for Techa riverside Residents).

Authors:  Evgenia I Tolstykh; Marina O Degteva; Alexandra V Vozilova; Lynn R Anspaugh
Journal:  Radiat Environ Biophys       Date:  2017-09-09       Impact factor: 1.925

9.  Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells.

Authors:  Stephan Klöß; Nicole Chambron; Tanja Gardlowski; Lubomir Arseniev; Joachim Koch; Ruth Esser; Wolfgang Glienke; Oliver Seitz; Ulrike Köhl
Journal:  Oncoimmunology       Date:  2015-05-29       Impact factor: 8.110

10.  A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.

Authors:  Christopher C Dvorak; Biljana N Horn; Jennifer M Puck; Stuart Adams; Paul Veys; Agnieszka Czechowicz; Morton J Cowan
Journal:  Pediatr Transplant       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.